+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latanoprost for Open-angle Glaucoma Market - Global Forecast 2026-2032- Product Image
Latanoprost for Open-angle Glaucoma Market - Global Forecast 2026-2032- Product Image
Sale

Latanoprost for Open-angle Glaucoma Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118345
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Latanoprost for Open-angle Glaucoma Market is projected to reach USD 1.66 Billion in 2026. It is expected to continue growing at a CAGR of 4.65%, reaching USD 2.19 Billion by 2032.

Latanoprost for Open-Angle Glaucoma: Executive Overview

Latanoprost is a prostaglandin analogue used to reduce elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Its clinical value stems from sustained pressure reduction with once-daily administration, supporting long-term disease management and helping reduce the risk of optic-nerve damage and visual-field loss. Treatment decisions depend on diagnosis, disease severity, tolerability, adherence, contraindications, and access to ophthalmic care.

Treatment Priorities Are Shifting Toward Adherence and Individualization

The treatment landscape is moving beyond pressure reduction alone toward consistent adherence, preservation of visual function, and patient-centered care. Clinicians increasingly consider dosing convenience, ocular-surface tolerability, preservative exposure, combination therapy, and the practical barriers that cause missed doses. Earlier detection, expanded screening, generic availability, and integration of medication with laser or surgical options are also influencing how open-angle glaucoma is managed.

Artificial Intelligence Strengthens Detection, Monitoring, and Treatment Support

Artificial intelligence is contributing to glaucoma care through analysis of retinal images, optic-nerve appearance, and visual-field data. These tools may support earlier identification of suspicious changes, triage in settings with limited specialist capacity, and longitudinal monitoring when validated against clinical standards. AI does not replace comprehensive examination, intraocular-pressure assessment, gonioscopy where indicated, or clinician judgment; its practical impact depends on data quality, regulatory oversight, workflow integration, and equitable access.

Regional Insights: Access, Diagnosis, and Care Capacity Shape Adoption

In North America and Europe, established ophthalmology services, guideline-based care, and broad access to pressure-lowering medicines support structured treatment pathways, while affordability and adherence remain important considerations. Asia-Pacific combines substantial clinical need with uneven specialist availability, creating opportunities for primary-care referral systems, teleophthalmology, and cost-sensitive treatment strategies. Latin America faces variation in diagnosis, reimbursement, and medicine availability across health systems. The Middle East is characterized by differences in specialist capacity and healthcare investment, while Africa continues to encounter major barriers involving screening, diagnosis, continuity of treatment, and access to ophthalmic medicines.

Group Insights: Economic and Institutional Blocs Have Different Care Priorities

ASEAN markets commonly require approaches that address fragmented healthcare delivery, urban-rural access gaps, and medicine affordability. BRICS members span diverse regulatory, reimbursement, and specialist-care environments, making local evidence and reliable distribution important. The European Union benefits from coordinated scientific and regulatory frameworks but retains national differences in reimbursement and service delivery. G7 health systems generally have mature diagnostic infrastructure while focusing on aging populations, adherence, and healthcare efficiency. GCC countries often combine concentrated specialist services with strong investment capacity, whereas NATO members represent varied health systems whose common priorities include resilience of medical supply and continuity of care.

Country Insights: National Health Systems Determine Treatment Pathways

Australia and Canada emphasize specialist access across geographically dispersed populations. Brazil and Mexico must address regional disparities in diagnosis, reimbursement, and medicine availability. China and India face large patient populations alongside differences between major cities and underserved areas. France, Germany, Italy, Spain, and the United Kingdom operate within established European care frameworks, with national variation in reimbursement, prescribing, and referral practices. Japan and South Korea have advanced clinical infrastructure and aging populations, increasing attention to chronic-care adherence and monitoring. Russia’s care environment is shaped by regional access, procurement, and healthcare-system constraints. The United States combines extensive specialist capacity with ongoing concerns about affordability, coverage, and persistence with therapy.

Action Priorities for Leaders in Glaucoma Care

Industry leaders should prioritize clinically appropriate access, dependable supply, and evidence that reflects real-world adherence and tolerability. Patient-support initiatives can focus on correct instillation technique, refill continuity, preservative-related concerns, and timely follow-up. Partnerships with ophthalmologists, primary-care providers, pharmacies, and public-health programs can improve case finding and referral. Digital monitoring and AI-enabled tools should be introduced with transparent validation, privacy safeguards, clinician oversight, and measurement of outcomes across demographic and geographic groups. Regional strategies should adapt to local reimbursement rules, workforce capacity, procurement systems, and health-literacy needs.

Research Methodology: Evidence-Based Synthesis of Clinical and Health-System Factors

This executive summary uses the defined market scope of latanoprost for open-angle glaucoma and synthesizes established clinical, regulatory, access, and health-system considerations. The analysis is organized across the specified regions, economic and institutional groups, and countries. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Interpretations should be corroborated with current clinical guidelines, regulatory documents, peer-reviewed ophthalmology research, pharmacovigilance information, and national reimbursement and prescribing policies.

Conclusion: Effective Use Depends on Reliable Long-Term Care

Latanoprost remains an important option for lowering intraocular pressure in open-angle glaucoma, but its real-world benefit depends on accurate diagnosis, appropriate prescribing, sustained adherence, tolerability, and regular monitoring. Regional and national differences in healthcare capacity will continue to shape access and outcomes. The strongest strategies combine clinically sound treatment with patient education, resilient supply, earlier detection, responsible use of digital tools, and coordinated follow-up aimed at preserving vision over the long term.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Latanoprost for Open-angle Glaucoma Market, by Formulation
7.1. Introduction
7.2. Preservative Free
7.3. Standard Eye Drop
7.4. Sustained Release
8. Latanoprost for Open-angle Glaucoma Market, by Product Type
8.1. Introduction
8.2. Brand Drugs
8.3. Generic Drugs
9. Latanoprost for Open-angle Glaucoma Market, by Age Group
9.1. Introduction
9.2. Adults
9.3. Geriatric
9.4. Pediatric
10. Latanoprost for Open-angle Glaucoma Market, by Application
10.1. Introduction
10.2. Combination Therapy
10.3. Monotherapy
11. Latanoprost for Open-angle Glaucoma Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Latanoprost for Open-angle Glaucoma Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Latanoprost for Open-angle Glaucoma Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Latanoprost for Open-angle Glaucoma Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Latanoprost for Open-angle Glaucoma Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Ajanta Pharma Limited
17.2. Apotex Inc.
17.3. Beximco Pharmaceuticals Ltd.
17.4. C-squared PHARMA Limited
17.5. Cipla Ltd.
17.6. Dr. Reddy's Laboratories Limited
17.7. FDC Limited
17.8. Gland Pharma Limited
17.9. Indoco Remedies Ltd
17.10. Lupin Limited
17.11. Micro Labs Ltd.
17.12. Pfizer Inc.
17.13. Santen Pharmaceutical Co., Ltd.
17.14. Sun Pharmaceutical Industries Ltd.
17.15. Taj Pharma Pvt. Ltd.
17.16. Teva Pharmaceutical Industries Ltd.
17.17. Viatris Inc.
17.18. Zivira Labs Pvt Ltd
17.19. Zizhu Pharmaceutical
17.20. Zydus Cadila
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Latanoprost for Open-angle Glaucoma Market, Years Considered for the Study
FIGURE 2. Global Latanoprost for Open-angle Glaucoma Market, Research Design
FIGURE 3. Global Latanoprost for Open-angle Glaucoma Market, Research Framework
FIGURE 4. Global Latanoprost for Open-angle Glaucoma Market, Data Triangulation
FIGURE 5. Global Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 7. Global Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Latanoprost for Open-angle Glaucoma Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Latanoprost for Open-angle Glaucoma Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Latanoprost for Open-angle Glaucoma Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Latanoprost for Open-angle Glaucoma Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Latanoprost for Open-angle Glaucoma Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Latanoprost for Open-angle Glaucoma Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Latanoprost for Open-angle Glaucoma Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Latanoprost for Open-angle Glaucoma Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Latanoprost for Open-angle Glaucoma Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Latanoprost for Open-angle Glaucoma Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Latanoprost for Open-angle Glaucoma Market Segmentation & Coverage
TABLE 2. Global Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 3. Global Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 4. Global Preservative Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Preservative Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Preservative Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Standard Eye Drop Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Standard Eye Drop Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Standard Eye Drop Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sustained Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sustained Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sustained Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 14. Global Brand Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Brand Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Brand Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Generic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Generic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Generic Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 21. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 31. Global Combination Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Combination Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Combination Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Monotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Monotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Monotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 38. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 48. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. North America Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. North America Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 67. North America Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. North America Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 69. North America Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. North America Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. North America Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Latin America Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 74. Latin America Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. Latin America Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 76. Latin America Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Latin America Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Latin America Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Europe Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Europe Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 81. Europe Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. Europe Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 83. Europe Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Europe Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Europe Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Middle East Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Middle East Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 88. Middle East Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Middle East Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 90. Middle East Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Middle East Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Africa Latanoprost for Open-angle Glaucoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 95. Africa Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. Africa Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 97. Africa Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Africa Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Africa Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Global Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 103. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. ASEAN Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. GCC Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. GCC Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 110. GCC Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. GCC Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 112. GCC Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. GCC Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. GCC Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. European Union Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. European Union Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 117. European Union Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. European Union Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 119. European Union Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. European Union Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. European Union Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. BRICS Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. BRICS Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 124. BRICS Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. BRICS Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 126. BRICS Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. BRICS Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. BRICS Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. G7 Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. G7 Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 131. G7 Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. G7 Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 133. G7 Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. G7 Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. G7 Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. NATO Latanoprost for Open-angle Glaucoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. NATO Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 138. NATO Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. NATO Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 140. NATO Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. NATO Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. NATO Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. Global Latanoprost for Open-angle Glaucoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. United States Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 145. United States Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 146. United States Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. United States Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 148. United States Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. United States Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. United States Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. Canada Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 152. Canada Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 153. Canada Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Canada Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 155. Canada Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Canada Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Canada Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Mexico Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 159. Mexico Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 160. Mexico Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. Mexico Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 162. Mexico Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Mexico Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Mexico Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Brazil Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 166. Brazil Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 167. Brazil Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Brazil Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 169. Brazil Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Brazil Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Brazil Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 173. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 174. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 176. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. United Kingdom Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Germany Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 180. Germany Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 181. Germany Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Germany Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 183. Germany Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Germany Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Germany Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. France Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 187. France Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 188. France Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. France Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 190. France Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. France Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. France Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. Russia Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 194. Russia Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 195. Russia Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Russia Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 197. Russia Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Russia Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Russia Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Italy Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 201. Italy Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 202. Italy Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Italy Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 204. Italy Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Italy Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Italy Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Spain Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 208. Spain Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 209. Spain Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. Spain Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 211. Spain Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Spain Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Spain Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. China Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 215. China Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 216. China Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. China Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 218. China Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. China Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. China Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. India Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 222. India Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 223. India Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. India Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 225. India Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. India Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. India Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Japan Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 229. Japan Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 230. Japan Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. Japan Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 232. Japan Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Japan Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Japan Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Australia Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 236. Australia Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 237. Australia Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Australia Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 239. Australia Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Australia Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Australia Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. South Korea Latanoprost for Open-angle Glaucoma Market Size, 2017-2032 (USD Million)
TABLE 243. South Korea Latanoprost for Open-angle Glaucoma Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 244. South Korea Latanoprost for Open-angle Glaucoma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. South Korea Latanoprost for Open-angle Glaucoma Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 246. South Korea Latanoprost for Open-angle Glaucoma Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. South Korea Latanoprost for Open-angle Glaucoma Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. South Korea Latanoprost for Open-angle Glaucoma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. Global Latanoprost for Open-angle Glaucoma Market Share, by Key Player, 2025
TABLE 250. Global Latanoprost for Open-angle Glaucoma Market, Key Experts

Companies Mentioned

  • Ajanta Pharma Limited
  • Apotex Inc.
  • Beximco Pharmaceuticals Ltd.
  • C-squared PHARMA Limited
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Limited
  • FDC Limited
  • Gland Pharma Limited
  • Indoco Remedies Ltd
  • Lupin Limited
  • Micro Labs Ltd.
  • Pfizer Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharma Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zivira Labs Pvt Ltd
  • Zizhu Pharmaceutical
  • Zydus Cadila

Related Topics

Related Reports

Open-Angle Glaucoma Therapeutics Market - Global Forecast 2026-2032 - Product Image

Open-Angle Glaucoma Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Glaucoma Market Report 2026 - Product Image

Glaucoma Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Glaucoma - Competitive Landscape, 2026 - Product Image

Glaucoma - Competitive Landscape, 2026

  • Report
  • 280 Pages
  • Global
From
Glaucoma Therapeutics Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035) - Product Image

Glaucoma Therapeutics Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

  • Report
  • 400 Pages
  • Global
From
Glaucoma Surgery Devices Market - Global Forecast 2026-2032 - Product Image

Glaucoma Surgery Devices Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.